Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Thoracic Disease|July 10, 2024
Recommendations for broadening eligibility criteria in esophagus cancer clinical trials: the mortality disparity of esophagus cancer as a first or second primary malignancyJinhang Leng, Hongrui Qiu, Qizhi Huang, et al.
Journal of Intellectual & Developmental Disability|September 22, 2025
Teachers' knowledge, belief, and experience regarding sex education for students with intellectual and developmental disabilities in ChinaQichao Pan, Yi Yang, Moon Young Savana Bak, et al.
Journal of the Endocrine Society|December 13, 2024
Role of Cancer History in Cardiovascular Mortality Among Different Age-group Patients With Differentiated Thyroid CancerHongrui Qiu, Wenyi Zhou, Qizhi Huang, et al.
Frontiers in Nephrology|September 7, 2023
Analysis of risk factors for severe acute kidney injury in patients with acute myocardial infarction: A retrospective studyYuxin Nong, Xuebiao Wei, Hongrui Qiu, et al.
Small (Weinheim an Der Bergstrasse, Germany)|June 2, 2026
Biomimetic TME-Responsive Nanotheranostics for Precise NIR-II Ratiometric Photoacoustic Imaging and Synergistic Immuno-Photothermal TherapyXin Li, Hongrui Qiu, Lik Hang Hugo Tse, et al.
Journal of Cancer Research and Clinical Oncology|September 1, 2023
Radiation-sensitive genetic prognostic model identifies individuals at risk for radiation resistance in head and neck squamous cell carcinomaPeimeng You, Shengbo Liu, Qiaxuan Li, et al.
Materials Today. Bio|April 9, 2026
Macrophage exosome-engineered nanoplatform with pH-responsive ratiometric photoacoustic and NIR-II fluorescence imaging for guided photothermal immunotherapy of hepatocellular carcinomaWenya Li, Xingyang Zhao, Hongrui Qiu, et al.
Discover Oncology|May 8, 2024
Pan-cancer analysis for the prognostic and immunological role of CD47: interact with TNFRSF9 inducing CD8 + T cell exhaustionHongxin Liang, Yong Zheng, Zekai Huang, et al.
Frontiers in Immunology|September 30, 2022
Combining autophagy and immune characterizations to predict prognosis and therapeutic response in lung adenocarcinomaQiaxuan Li, Daipeng Xie, Lintong Yao, et al.
Theranostics|August 4, 2025
NIR-II light-driven <i>in situ</i> nanovaccine for cancer immunotherapy via lymph node migration-mediated accumulationYucheng Huang, Miao Su, Weihuan Lin, et al.
Pageof 2